Cart
sales@molnova.com
Biotin-Kinase Domain of Insulin Receptor (2)
CAS No. ———
Biotin-Kinase Domain of Insulin Receptor (2)( ——— )
Catalog No. M41561 CAS No. ———
Biotin-Kinase Domain of Insulin Receptor (2)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameBiotin-Kinase Domain of Insulin Receptor (2)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBiotin-Kinase Domain of Insulin Receptor (2)
-
DescriptionBiotin-Kinase Domain of Insulin Receptor (2)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1929.07
-
Molecular FormulaC72H122N21O29S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
N-Valyltryptophan
N-Valyltryptophan is an incomplete breakdown product of protein catabolism or protein digestion.
-
FEN1-IN-3
FEN1-IN-3 is a human flap endonuclease-1 ( hFEN1 ) inhibitor that stabilizes hFEN1 with an EC 50 of 6.8 μM .
-
Atezolizumab
Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.
